Aceto announced its acquisition of A&C. The acquisition helps to drive Aceto’s growth strategy, increasing the company’s GMP manufacturing, packaging, and ingredients offerings for the cell culture, vaccine, and biopharmaceutical industries, while also expanding its North American footprint. A&C solves customers' technical, product and regulatory challenges through GMP custom ingredient development, manufacturing, and packaging in the life science sector. With A&C, Aceto now provides customers greater access to critical raw materials and excipients used in synthesizing biologics, as well as enhanced support throughout the drug development process.